These results, along with a past report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 assist the notion of targeting ACKR3 as a novel technique to modulate the opioid program, which could open new therapeutic avenues for opioid-linked disorders. A study research revealed in Anesthesiology https://erica811wiq8.tkzblog.com/profile